Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer
Condition(s):Breast CancerLast Updated:October 19, 2020Terminated
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:October 19, 2020Terminated
Condition(s):Solid TumoursLast Updated:July 25, 2017Terminated
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:April 23, 2021Unknown status
Condition(s):Renal Failure; Chronic Kidney Disease Requiring Chronic DialysisLast Updated:November 22, 2023Completed
Condition(s):Breast CancerLast Updated:December 10, 2013Unknown status
Condition(s):Chronic Kidney Disease; Cardiovascular DiseaseLast Updated:August 26, 2022Completed
Condition(s):Adenocarcinoma of the Pancreas; Recurrent Pancreatic Cancer; Stage III Pancreatic Cancer; Stage IV Pancreatic CancerLast Updated:July 31, 2020Completed
Condition(s):Persistent Post-concussive Syndrome; Concussion Post SyndromeLast Updated:January 5, 2024Active, not recruiting
Condition(s):Benign Intracranial HypertensionLast Updated:March 7, 2023Recruiting
Condition(s):Colorectal CancerLast Updated:August 30, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.